Pennant Net Income 2018-2023 | PNTG
Pennant net income from 2018 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Pennant Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $13 |
| 2022 | $7 |
| 2021 | $3 |
| 2020 | $16 |
| 2019 | $3 |
| 2018 | $16 |
| 2017 | $10 |
| Pennant Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $4 |
| 2023-09-30 | $4 |
| 2023-06-30 | $3 |
| 2023-03-31 | $2 |
| 2022-12-31 | $3 |
| 2022-09-30 | $5 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $1 |
| 2021-12-31 | $-2 |
| 2021-09-30 | $1 |
| 2021-06-30 | $3 |
| 2021-03-31 | $1 |
| 2020-12-31 | $4 |
| 2020-09-30 | $4 |
| 2020-06-30 | $4 |
| 2020-03-31 | $3 |
| 2019-12-31 | $-4 |
| 2019-09-30 | $2 |
| 2019-06-30 | $3 |
| 2019-03-31 | $1 |
| 2018-12-31 | |
| 2018-09-30 | $4 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.622B | $0.545B |
| The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.509B | 9.99 |
| Quest Diagnostics (DGX) | United States | $15.276B | 15.79 |
| DaVita (DVA) | United States | $11.641B | 15.84 |
| Chemed (CHE) | United States | $9.342B | 29.00 |
| Encompass Health (EHC) | United States | $8.292B | 21.34 |
| Elanco Animal Health (ELAN) | United States | $6.576B | 14.95 |
| Option Care Health (OPCH) | United States | $5.202B | 19.69 |
| RadNet (RDNT) | United States | $3.333B | 97.34 |
| Amedisys (AMED) | United States | $2.974B | 21.08 |
| LifeStance Health (LFST) | United States | $2.358B | 0.00 |
| Astrana Health (ASTH) | United States | $2.051B | 25.88 |
| U.S Physical Therapy (USPH) | United States | $1.562B | 40.49 |
| Addus HomeCare (ADUS) | United States | $1.550B | 23.76 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.444B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.313B | 0.00 |
| Daxor (DXR) | United States | $0.047B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.017B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| Ontrak (OTRK) | United States | $0.009B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |